273207-57-1

Basic information

• Product Name: 3-Methylene-8-Boc-8-Azabicyclo[3.2.1]Octane
• Synonyms: 3-Methylene-8-Boc-8-Azabicyclo[3.2.1]Octane;tert-butyl 3-methylidene-8-azabicyclo[3.2.1]octane-8-carboxylate
• CAS NO: 273207-57-1
• Molecular Formula: C13H21NO2
• Molecular Weight: 223.32
• Mol File: 273207-57-1.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 294.1±29.0 °C(Predicted)
• Appearance: /
• Density: 1.05±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: -1.53±0.20(Predicted)
• CAS DataBase Reference: 3-Methylene-8-Boc-8-Azabicyclo[3.2.1]Octane(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Methylene-8-Boc-8-Azabicyclo[3.2.1]Octane(273207-57-1)
• EPA Substance Registry System: 3-Methylene-8-Boc-8-Azabicyclo[3.2.1]Octane(273207-57-1)

Safety Data

• Hazardous Substances Data: 273207-57-1(Hazardous Substances Data)

Usage

General Description

3-Methylene-8-Boc-8-Azabicyclo[3.2.1]Octane is a chemical compound with a complex structure containing a bicyclic skeleton and various functional groups. The name "3-Methylene" indicates the presence of a methylene group at the third carbon atom of the molecule, while "8-Boc" refers to a tert-butoxycarbonyl group attached to the eighth carbon atom. The "8-Azabicyclo[3.2.1]Octane" portion of the name signifies the presence of a nitrogen atom in the bicyclic ring system. 3-Methylene-8-Boc-8-Azabicyclo[3.2.1]Octane has potential applications in organic synthesis and medicinal chemistry, particularly in the development of pharmaceuticals and bioactive molecules due to its unique structure and functional groups. Further research and analysis are necessary to fully understand the properties and potential uses of this chemical.

Upstream product

• 1779-49-3 Methyltriphenylphosphonium bromide 
• 185099-67-6 Boc-tropinone 
• 1031-15-8 methyltriphenylphosphonium chloride 
• 2065-66-9 methyl-triphenylphosphonium iodide 

Downstream Products

• 799283-62-8 tert-butyl 3-(hydroxymethyl)-8-azabicyclo[3.2.1]octane-8-carboxylate 
• 60941-77-7 8-azabicyclo[3.2.1]octan-3-ylmethanol 

Relevant articles and documents

INHIBITORS OF HISTONE DEACETYLASE USEFUL FOR THE TREATMENT OR PREVENTION OF HIV INFECTION

The present invention relates to Compounds of Formula I: and pharmaceutically acceptable salts or prodrug thereof, wherein R1, R2, R3, R4 and A are as defined herein. The present invention also relates to compos

Dehydroxymethylation of Alcohols Enabled by Cerium Photocatalysis

Dehydroxymethylation, the direct conversion of alcohol feedstocks as alkyl synthons containing one less carbon atom, is an unconventional and underexplored strategy to exploit the ubiquity and robustness of alcohol materials. Under mild and redox-neutral reaction conditions, utilizing inexpensive cerium catalyst, the photocatalytic dehydroxymethylation platform has been furnished. Enabled by ligand-to-metal charge transfer catalysis, an alcohol functionality has been reliably transferred into nucleophilic radicals with the loss of one molecule of formaldehyde. Intriguingly, we found that the dehydroxymethylation process can be significantly promoted by the cerium catalyst, and the stabilization effect of the fragmented radicals also plays a significant role. This operationally simple protocol has enabled the direct utilization of primary alcohols as unconventional alkyl nucleophiles for radical-mediated 1,4-conjugate additions with Michael acceptors. A broad range of alcohols, from simple ethanol to complex nucleosides and steroids, have been successfully applied to this fragment coupling transformation. Furthermore, the modularity of this catalytic system has been demonstrated in diversified radical-mediated transformations including hydrogenation, amination, alkenylation, and oxidation.

NOVEL KINASE INHIBITORS

The present invention provides derivatives of thiazolylamino-substituted heterocycles. These compounds are inhibitors of kinases, including compounds that show antiproliferative activity against cells, including against tumor cells, and are useful in the treatment of diseases including cancer.